查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1832016

2025 年至 2033 年局部疼痛缓解市场规模、份额、趋势及预测（按治疗类别、剂型、类型、配销通路和地区划分）

Topical Pain Relief Market Size, Share, Trends and Forecast by Therapeutic Class, Formulation, Type, Distribution Channel, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球局部止痛药市场规模达110亿美元。展望未来， IMARC Group预测，到2033年，该市场规模将达到173亿美元，2025-2033年的复合年增长率为5.1%。目前，北美占据市场主导地位，2024年的市占率将超过35.0%。非阿片类镇痛药需求的不断增长、老龄化人口的不断扩大、消费者对非处方药（OTC）产品的偏好增强、产品配方的持续创新以及通过电子商务和零售药店的广泛普及，都是推动北美局部止痛药市场份额增长的一些因素。

关节炎、背痛和肌肉骨骼疾病病例的增多，加剧了对有针对性的疼痛管理解决方案的需求，从而扩大了局部疼痛缓解市场的需求。这些疾病在老化人群和久坐不动的人群中较为常见，因此亟需有效且易于取得的治疗方法。此外，许多人更倾向于外用药物而非口服药物，以降低全身副作用的风险。外用製剂能够局部缓解疼痛，并且被认为更适合长期使用，因此成为治疗慢性疼痛的首选。此外，持续的创新也推动了先进产品的开发，包括快速吸收凝胶、长效贴片和天然成分解决方案。这些改进提升了使用者体验和疗效，从而提高了产品的采用率。此外，各公司正在进行针对性的行销活动和产品广告，向使用者宣传局部疼痛缓解的益处，从而提高产品的知名度和接受度。

美国在局部止痛药市场的成长中扮演着至关重要的角色，这得益于老年人口的成长，他们更容易患上关节痛、骨关节炎和其他肌肉骨骼疾病。此外，电子商务管道的不断增加也提高了买家的可及性和便利性。数位平台提供多样化的产品选择、全面的资讯和具有竞争力的价格，使用户能够做出明智的购买决策。便利的送货上门和线上产品比较功能提高了产品的采用率，尤其是在技术娴熟的人群中。生产商和销售商正在利用数位平台来扩大受众，提供独家线上促销、会员资格和个人化行销策略。使用者友善介面和安全支付选项的日益融合进一步鼓励买家转向线上购物，使电子商务成为市场成长的重要因素。 2024年11月，美国商务部人口普查局宣布，预计2024年第三季美国零售电子商务销售额将达到3,001亿美元，比2024年第二季成长2.6%。

局部疼痛缓解市场趋势：

关节炎和肌肉骨骼疾病的盛行率不断上升

局部止痛产品，包括乳膏、凝胶和贴剂，能够标靶缓解疼痛，且与口服药物相比，全身副作用风险较低，因此成为许多人的首选。根据世界卫生组织 (WHO) 的数据，全球约有 17.1 亿人患有肌肉骨骼疾病，这推动了对局部疼痛管理解决方案的需求。局部止痛市场洞察表明，这些治疗方法对患有多种疾病和药物的老年人尤其有益，可以降低药物交互作用的风险。局部疗法作为口服止痛药的有效替代品，日益受到认可，显着扩大了市场。骨关节炎和类风湿性关节炎等疾病患者通常能够快速缓解局部不适，进而提高活动能力和整体生活品质。更好的吸收技术和缓释配方等改进进一步提高了使用者的参与度。此外，天然和有机产品的进步满足了人们对更安全、更永续治疗方案日益增长的需求。

药物传输技术的不断进步

药物传输技术的持续进步对于提升局部止痛产品的疗效至关重要，也是局部止痛市场的重要趋势。美国製药业为超过130万人提供了就业岗位，引领了微胶囊化、奈米製剂和透皮贴剂等创新给药机制的进步。这些技术有助于改善皮肤吸收、调控释放并精准靶向活性药物成分 (API)，从而增强疼痛管理效果。透过减少全身暴露和降低副作用，这些非侵入性技术满足了使用者日益增长的对比传统口服药物更安全选择的需求。此外，药物输送系统的改进使得现有药物能够进行再利用，透过提高其有效性和患者依从性来重振旧有 API。各公司也正在研究整合各种技术的混合系统，例如将微针与封装 API 结合，这进一步拓展了创新潜力。

增加研发投入

局部止痛市场研究报告显示，药厂增加研发投入，推动先进製剂的开发，进而提高疗效、延长药效持续时间并减少副作用。这些措施还包括研究具有止痛功效的新型活性成分和天然物质，以满足市场对有机和天然替代品日益增长的需求。全球止痛药市场规模预计在2024年达到5,63亿美元，凸显了止痛解决方案的巨大发展潜力。製药公司正在利用研发成果，打造创新的给药系统，例如速效凝胶和持久贴剂，以提供针对性的缓解。此外，製药公司也致力于拓展产品系列，提供不同的强度和活性成分，以满足从轻度到重度止痛的各种用户需求。这些进步提升了产品性能，并帮助公司在竞争激烈的市场中脱颖而出。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球局部止痛药市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依治疗类别

  • 非阿片类药物
  • 阿片类药物

第七章：市场区隔：依公式

  • 奶油
  • 凝胶
  • 喷
  • 修补
  • 其他的

第八章：市场区隔：依类型

  • 处方止痛药
  • 非处方止痛药

第九章：市场区隔：按配销通路

  • 药局和药局
  • 零售店
  • 网上商店

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 11 章：SWOT 分析

第 12 章：价值链分析

第 13 章：波特五力分析

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Advacare Pharma
    • Exzell Pharma Inc.
    • Glaxosmithkline Plc
    • Johnson & Johnson
    • Novartis AG
    • Pfizer Inc.
    • Reckitt Benckiser Group Plc
    • Sanofi SA
    • Sun Pharmaceutical Industries Limited
    • Topical Biomedics Inc.
Product Code: SR112025A4441

The global topical pain relief market size was valued at USD 11.0 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 17.3 Billion by 2033, exhibiting a CAGR of 5.1% from 2025-2033. North America currently dominates the market, holding a market share of over 35.0% in 2024. The rising demand for non-opioid analgesics, expanding aging population, heightened consumer preference for OTC products, ongoing product innovations with enhanced formulations, and wider availability through e-commerce and retail pharmacies are some of the factors increasing the North America topical pain relief market share.

The rising cases of arthritis, back pain, and musculoskeletal disorders are fueling the need for targeted pain management solutions, which is increasing the topical pain relief market demand. These conditions are common among aging populations and individuals with sedentary lifestyles, emphasizing the need for effective and accessible treatments. Additionally, many individuals favor topical solutions over oral medications to reduce the risk of systemic side effects. Topical formulations offer localized relief and are considered safer for prolonged use, making them a preferred choice for managing chronic pain. Besides this, continuous innovation is leading to the development of advanced products, including fast-absorbing gels, long-lasting patches, and natural ingredient-based solutions. These enhancements improve user experience and efficacy, increasing adoption. Moreover, companies are adopting targeted marketing campaigns and product-specific advertisements to educate users about the benefits of topical pain relief, driving product awareness and acceptance.

The United States plays a crucial role in topical pain relief market growth, driven by the growing geriatric demographic that is more prone to conditions like joint pain, osteoarthritis, and other musculoskeletal disorders. Furthermore, the increasing number of e-commerce channels are enhancing accessibility and convenience for buyers. Digital platforms offer a diverse array of product choices, comprehensive details, and competitive pricing, allowing users to make well-informed buying decisions. The ease of home delivery and the option to compare products online lead to higher adoption rates, especially among tech-savvy people. Producers and sellers are utilizing digital platforms to broaden their audience, providing exclusive online promotions, memberships, and personalized marketing strategies. The increasing integration of user-friendly interfaces and secure payment options further encourages buyers to shift towards online purchases, making e-commerce a vital factor for the market growth. In November 2024, the Census Bureau of the Department of Commerce announced that the projected US retail e-commerce sales for the third quarter of 2024 reached $300.1 billion, indicating an increase of 2.6 percent compared to the second quarter of 2024.

Topical Pain Relief Market Trends:

Increasing prevalence of arthritis and musculoskeletal disorders

Topical pain relief options, including creams, gels, and patches, offer targeted pain alleviation with a lower risk of systemic side effects compared to oral medications, making them a preferred choice for many. According to the World Health Organization (WHO), around 1.71 billion people globally suffer from musculoskeletal disorders, driving the demand for localized pain management solutions. Topical pain relief market insights highlight that these treatments are particularly beneficial for seniors dealing with multiple health conditions and medications, reducing the risks of drug interactions. The growing endorsement of topical therapies as effective alternatives to oral pain relievers has significantly expanded the market. People experiencing conditions like osteoarthritis and rheumatoid arthritis often experience rapid relief from localized discomfort, improving their mobility and overall life quality. Improvements such as better absorption techniques and extended-release formulations further enhance user involvement. Additionally, the progress of natural and organic products addresses the increasing need for safer and more sustainable treatment options.

Continual advancements in drug delivery technologies

The ongoing progress in drug delivery technologies, which are crucial for improving the efficacy of topical pain relief items, is a significant topical pain relief market trend. The US pharmaceutical industry, which provides jobs for more than 1.3 million people, has led advancements in innovative delivery mechanisms like microencapsulation, nano-formulations, and transdermal patches. These technologies facilitate improved skin absorption, regulated release, and accurate targeting of active pharmaceutical ingredients (APIs), leading to enhanced pain management results. By decreasing systemic exposure and lowering side effects, these non-invasive techniques match the increasing user demand for safer options compared to conventional oral medications. Moreover, improvements in drug delivery systems allow for the reworking of current medications, revitalizing older APIs by boosting their effectiveness and patient adherence. Companies are also investigating hybrid systems that integrate various technologies, like microneedles with encapsulated APIs, which expands the potential for innovation even more.

Increased investment in research and development (R&D)

The topical pain relief market research report indicates that heightened research and development (R&D) investments from pharmaceutical firms are driving the development of advanced formulations with enhanced efficacy, longer action durations, and fewer side effects. These initiatives also include investigating novel active ingredients and natural substances with pain-relieving effects, responding to the increasing need for organic and natural alternatives. The worldwide analgesics market, estimated at USD 56.3 billion in 2024, underscores the vast potential for advancements in pain relief solutions. Pharmaceutical firms are utilizing R&D to create innovative drug delivery systems, like quick-absorbing gels and enduring patches, that offer focused relief. Additionally, initiatives aimed at expanding product ranges with different strengths and active components address a broad spectrum of user requirements, spanning from mild to intense pain relief. These advancements enhance product performance and assist companies in standing out in a fiercely competitive market.

Topical Pain Relief Industry Segmentation:

Analysis by Therapeutic Class:

  • Non-Opioids
  • Opioids

Non-opioids constitute the biggest segment with a market share of 72.8% due to their safety, efficacy, and lower likelihood of dependency in comparison to opioids. These items generally include active components like NSAIDs, menthol, or capsaicin, which are well-known for their capacity to reduce pain and inflammation without causing systemic side effects. Non-opioid pain relief options are frequently suggested for ailments such as arthritis, sprains, and muscle pain, offering focused and short-term alleviation. The segment gains from the increasing inclination towards non-invasive and over-the-counter alternatives, enabling people to handle minor pain issues without requiring prescriptions. Regulatory backing and public health programs encouraging the adoption of safer alternatives to opioids additionally foster this segment's expansion. Advancements in non-opioid products, such as sophisticated patches and quick-absorbing gels, are improving their efficacy and user satisfaction.

Analysis by Formulation:

  • Cream
  • Gel
  • Spray
  • Patch
  • Others

Patches dominate the market because of their efficiency, ease of use, and consistent release of active substances. These items deliver localized pain relief by sticking directly to the impacted area, guaranteeing focused effectiveness. In contrast to creams or gels, patches provide a steady, regulated release of medication, minimizing the necessity for constant reapplication and improving patient adherence. Their subtle design and simple operation make them a favored option for people dealing with ongoing issues such as arthritis or back pain. Moreover, patches reduce the chance of mess or residue, providing a tidy and convenient option. Technological progress is fostering the creation of cutting-edge patch designs, featuring enhanced adhesion, flexibility, and suitability for various skin types. Numerous patches are now blended with a mix of active components, including lidocaine, menthol, or capsaicin, to boost effectiveness.

Analysis by Type:

  • Prescription Pain Relief
  • Over the Counter (OTC) Pain Relief

Over-the-counter (OTC) pain relief segment dominates the market with a market share of 61.4%. It addresses the demand for accessible and convenient solutions for minor pain conditions. These products, including creams, gels, and patches, are widely used for temporary relief from muscle aches, sprains, and mild arthritis. The ease of purchase without a prescription and the availability in pharmacies, supermarkets, and online platforms make OTC pain relief highly popular. Active ingredients such as menthol, capsaicin, and diclofenac are commonly included, ensuring quick and effective relief.

Analysis by Distribution Channel:

  • Pharmacy and Drug Stores
  • Retail Stores
  • Online Stores

Online stores lead the market with a market share of 56.0% due to their ease of use, extensive product selection, and attractive pricing. These platforms offer convenient access to a variety of products, enabling consumers to evaluate choices and make knowledgeable decisions from the ease of their residences. The rise in e-commerce adoption, fueled by greater internet access and smartphone usage, is further supporting the market growth. Numerous online merchants provide comprehensive product descriptions, customer reviews, and suggestions, boosting buyer confidence and streamlining the buying experience. Moreover, appealing discounts, subscription options, and rapid delivery services enhance their attractiveness. Producers are also leveraging this trend by collaborating with leading e-commerce platforms and enhancing their online stores. Due to their constant availability and worldwide accessibility, online retailers are surpassing conventional distribution methods in the topical pain relief sector.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America is the biggest segment with a market share of 35.0%, supported by various factors including a high rate of chronic pain disorders, a sophisticated healthcare system, and rising investments in research and development (R&D). The region's elderly population contributes to an increasing prevalence of issues such as musculoskeletal disorders and arthritis, enhancing the need for efficient pain management strategies. The extensive use of over-the-counter products, along with the presence of prescription-based alternatives, increases consumer access to topical pain relief choices. Moreover, positive reimbursement policies and robust backing from regulatory agencies foster innovation and the launch of new formulations. North America's proactive healthcare strategies, along with its emphasis on pain management education, position it as a leader in this sector, guaranteeing ongoing market growth and the uptake of innovative products. In 2024, Wellness Formulations, LLC introduced ralli(TM) Rapid Pain Relief, a groundbreaking topical analgesic sold at Walmart. With 10% menthol and natural components such as MSM, glucosamine, and Boswellia, it provides instant relief from muscle and joint discomfort. The product is available in gel, spray, and roll-on variations, enhancing both affordability and accessibility.

Key Regional Takeaways:

United States Topical Pain Relief Market Analysis

The market in the United States is growing with a market share of 91.50%, fueled by the growing incidence of chronic ailments and an escalating inclination towards non-invasive pain management options. Approximately 129 million individuals in the US experience at least one significant chronic illness, including heart disease, cancer, diabetes, obesity, or hypertension, according to the US Department of Health and Human Services. Such circumstances frequently result in ongoing discomfort, especially joint pain, muscle strain, and back pain, increasing the need for topical pain relievers. With increasing worries about opioids, people are looking for alternative pain relief methods, and topical solutions such as creams, gels, and patches provide effective pain control without the dangers linked to oral medications. Moreover, the older population, especially susceptible to ailments such as arthritis, is increasing the demand for specific, localized pain relief. Moreover, advancements in product compositions, like CBD-infused topical pain relievers, are also broadening user options, aiding the widespread acceptance of topical pain relief products.

Europe Topical Pain Relief Market Analysis

Europe's topical pain relief market outlook is significantly influenced by the region's aging population and the growing prevalence of chronic pain conditions. As of January 1, 2023, the population of the European Union was 448.8 million, with more than one-fifth (21.3%) being 65 years or older, as reported by Eurostat. Elderly individuals are more vulnerable to ailments such as osteoarthritis, back discomfort, and joint pain, increasing the need for efficient pain relief options. With the growing interest in non-invasive therapies, more people are opting for topical analgesics like creams, gels, and patches, which provide focused relief with reduced side effects when compared to oral drugs. Moreover, the increase in health consciousness and the accessibility of over-the-counter items in drugstores and online retailers are also driving the market growth. Product formulation innovations, incorporating natural components such as CBD, are increasingly popular, drawing users who desire safer, more sustainable options. With the increasing need for localized pain relief, the European market for topical pain relief products is set for ongoing growth.

Asia Pacific Topical Pain Relief Market Analysis

In the Asia-Pacific (APAC) area, the rising incidence of musculoskeletal disorders and the heightened need for non-invasive pain management options are fueling the topical pain relief market. As reported by PubMed Central, a notable segment of older Asian communities experiences knee pain, with prevalence rates varying from 11% to 56% in China, 33% in Japan, 38% in Korea, and 61% in Vietnam. The increasing occurrence of joint pain, especially in older adults, is generating a significant need for efficient, localized pain relief solutions. Moreover, people are progressively choosing topical therapies because of their ease of use, reduced side effects, and availability. The growing healthcare infrastructure in developing regions such as India and Southeast Asia additionally supports market expansion, along with increased awareness of the advantages of topical analgesics compared to conventional oral medications.

Latin America Topical Pain Relief Market Analysis

In Latin America, the rising incidence of chronic illnesses are significantly propelling the market growth. As reported by PubMed Central, Brazil is believed to have approximately 928,000 fatalities each year as a result of chronic diseases. As a significant part of the population suffers from ailments such as arthritis, back pain, and joint problems, the need for effective pain relief options is increasing. Topical analgesics like creams and gels are becoming increasingly popular as non-invasive substitutes for oral medications. As individuals pursue more convenient and secure alternatives for pain relief, the market for topical analgesic products keeps growing. These factors contribute to topical pain relief market revenue in emerging markets.

Middle East and Africa Topical Pain Relief Market Analysis

In the Middle East, chronic diseases are notably prevalent, especially in the UAE, where 23.0% of individuals report having chronic conditions like obesity, diabetes, and asthma/allergies, as noted by PubMed Central. The increasing prevalence of these chronic illnesses is driving the need for pain relief options, such as topical analgesics. As people seek non-invasive methods to alleviate pain from issues like joint discomfort and muscle strain, the market for topical pain relief solutions is set for expansion. This trend is enhanced by the growing awareness about the advantages of topical therapies compared to conventional oral medications in the area.

Competitive Landscape:

Major participants in the market are currently concentrating on product development, broadening their distribution channels, and improving marketing tactics to bolster their market presence. They are allocating resources towards research activities to develop innovative formulations, including quick-absorbing gels and durable patches, addressing various user requirements. Strategic collaborations with healthcare providers and retail channels are improving accessibility. Many are leveraging digital platforms to increase user engagement and awareness about their products. Sustainability initiatives, including eco-friendly packaging, are also gaining attention to align with individual preferences. Additionally, these companies are expanding their product portfolios to include natural and organic options, addressing the growing demand for safer and chemical-free alternatives. In August 2023, Johnson & Johnson introduced a new pain remedy, the topical Tylenol(R) Precise(TM) Pain Relieving Cream. Tylenol Precise accommodates active lifestyles with a fast-absorbing formula, odorless and fresh scent variants for subtle use, and a specially crafted rollerball for hands-free, clean application that keeps skin free from sticky residues.

The report provides a comprehensive analysis of the competitive landscape in the topical pain relief market with detailed profiles of all major companies, including:

  • Advacare Pharma
  • Exzell Pharma Inc.
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited
  • Topical Biomedics Inc.

Key Questions Answered in This Report

  • 1.How big is the topical pain relief market?
  • 2.What is the future outlook of topical pain relief market?
  • 3.What are the key factors driving the topical pain relief market?
  • 4.Which region accounts for the largest topical pain relief market share?
  • 5.Which are the leading companies in the global topical pain relief market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Topical Pain Relief Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapeutic Class

  • 6.1 Non-Opioids
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Opioids
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Formulation

  • 7.1 Cream
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gel
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Spray
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Patch
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Type

  • 8.1 Prescription Pain Relief
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Over the Counter (OTC) Pain Relief
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Pharmacy and Drug Stores
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Stores
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Stores
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Advacare Pharma
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Exzell Pharma Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Glaxosmithkline Plc
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Johnson & Johnson
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Novartis AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Pfizer Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Reckitt Benckiser Group Plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Sanofi S.A.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Sun Pharmaceutical Industries Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Topical Biomedics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Topical Pain Relief Market: Major Drivers and Challenges
  • Figure 2: Global: Topical Pain Relief Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Topical Pain Relief Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Topical Pain Relief Market: Breakup by Therapeutic Class (in %), 2024
  • Figure 5: Global: Topical Pain Relief Market: Breakup by Formulation (in %), 2024
  • Figure 6: Global: Topical Pain Relief Market: Breakup by Type (in %), 2024
  • Figure 7: Global: Topical Pain Relief Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Topical Pain Relief Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Topical Pain Relief (Non-Opioids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Topical Pain Relief (Non-Opioids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Topical Pain Relief (Opioids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Topical Pain Relief (Opioids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Topical Pain Relief (Cream) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Topical Pain Relief (Cream) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Topical Pain Relief (Gel) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Topical Pain Relief (Gel) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Topical Pain Relief (Spray) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Topical Pain Relief (Spray) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Topical Pain Relief (Patch) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Topical Pain Relief (Patch) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Topical Pain Relief (Other Formulations) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Topical Pain Relief (Other Formulations) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Topical Pain Relief (Prescription Pain Relief) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Topical Pain Relief (Prescription Pain Relief) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Topical Pain Relief (Over the Counter (OTC) Pain Relief) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Topical Pain Relief (Over the Counter (OTC) Pain Relief) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Topical Pain Relief (Pharmacy and Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Topical Pain Relief (Pharmacy and Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Topical Pain Relief (Retail Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Topical Pain Relief (Retail Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Topical Pain Relief (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Topical Pain Relief (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: North America: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: North America: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: United States: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: United States: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Canada: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Canada: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Asia-Pacific: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Asia-Pacific: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: China: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: China: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Japan: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Japan: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: India: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: India: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: South Korea: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: South Korea: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Australia: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Australia: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Indonesia: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Indonesia: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Others: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Others: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Europe: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Europe: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Germany: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Germany: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: France: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: France: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: United Kingdom: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: United Kingdom: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Italy: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Italy: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Spain: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Spain: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Russia: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Russia: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Others: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Others: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Latin America: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Latin America: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Brazil: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Brazil: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Mexico: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Mexico: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Middle East and Africa: Topical Pain Relief Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Middle East and Africa: Topical Pain Relief Market: Breakup by Country (in %), 2024
  • Figure 81: Middle East and Africa: Topical Pain Relief Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Global: Topical Pain Relief Industry: SWOT Analysis
  • Figure 83: Global: Topical Pain Relief Industry: Value Chain Analysis
  • Figure 84: Global: Topical Pain Relief Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Topical Pain Relief Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Topical Pain Relief Market Forecast: Breakup by Therapeutic Class (in Million USD), 2025-2033
  • Table 3: Global: Topical Pain Relief Market Forecast: Breakup by Formulation (in Million USD), 2025-2033
  • Table 4: Global: Topical Pain Relief Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 5: Global: Topical Pain Relief Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Topical Pain Relief Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Topical Pain Relief Market: Competitive Structure
  • Table 8: Global: Topical Pain Relief Market: Key Players